How to cite item

Establishment of a novel cell-based assay for screening small molecule antagonists of human interleukin-6 receptor

  
@article{APS4489,
	author = {Yang-yang He and Yu Yan and Chang Zhang and Peng-yuan Li and Ping Wu and Peng Du and Da-di Zeng and Jian-song Fang and Shuang Wang and Guan-hua Du},
	title = {Establishment of a novel cell-based assay for screening small molecule antagonists of human interleukin-6 receptor},
	journal = {Acta Pharmacologica Sinica},
	volume = {35},
	number = {11},
	year = {2016},
	keywords = {},
	abstract = {Aim: Blockade of interleukin-6 (IL-6) or its receptor (IL-6R) is effective in preventing the progression of autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. In the present study, we established a novel cell-based assay for identifying small molecule IL-6R antagonists.
Methods: HEK293A cells were transfected with recombinant plasmids pTaglite-SNAP-IL6R and pABhFc-IL6 to obtain membrane-bound IL-6R and recombinant human IL-6 coupled with human Fc fragment (rhIL-6), respectively. A novel screening assay based on the interaction between IL-6R and rhIL-6 was established, optimized and validated. The stability of the assay was also assessed by calculating the Z′-factor.
Results: RhIL-6 dose-dependently bound to IL-6R expressed at HEK293A cell surface. The IC50 value of the known antagonist ab47215 was 0.38±0.08 μg/mL, which was consistent with that obtained using the traditional method (0.36±0.14 μg/mL). The value of Z′-factor was 0.68, suggesting that the novel assay was stable for high throughput screening. A total of 474 compounds were screened using the novel screening assay, and 3 compounds exhibited antagonistic activities (IC50=8.73±0.28, 32.32±9.08, 57.83±4.24 μg/mL). Furthermore, the active compounds dose-dependently inhibited IL-6-induced proliferation of 7TD1 cells, and reduced IL-6-induced STAT3 phosphorylation in U937 cells.
Conclusion: A novel cell-based screening assay for identifying small molecule IL-6R antagonists was established, which simplifies the procedures in traditional cellular ELISA screening and profiling and reduces the costs.},
	issn = {1745-7254},	url = {http://www.chinaphar.com/article/view/4489}
}